Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-17 | New | $4,920,000 | $4,920,000 | Equity Only | 06b | SEC link |
| 2024-01-29 | New | $6,000,000 | $6,000,000 | Other | 06b | SEC link |
| 2023-07-28 | New | $10,000,008 | $10,000,008 | Equity Only | 06b | SEC link |
| 2022-08-17 | New | $629,958 | $629,958 | Equity Only | 06b | SEC link |
| 2022-01-24 | New | $5,160,997 | $5,160,997 | Equity Only | 06b | SEC link |
| 2012-06-07 | New | $10,000,002 | $10,000,002 | Equity Only | 06 | SEC link |
| 2011-07-13 | New | $20,839,994 | $20,839,994 | Debt Only | 06 | SEC link |
| 2010-09-21 | New | $8,000,800 | $8,000,800 | Debt Only | 06 | SEC link |
| 2009-11-25 | New | $14,814,106 | Unknown | Equity Only | 06 | SEC link |
| 2008-02-19 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Adrian Adams | Director |
| Richard Afable | Director |
| Vincent J Angotti | Director, Executive |
| Raffi Asadorian | Executive |
| Shakil Aslam | Executive |
| Marina Bozilenko | Director |
| Jill Broadfoot | Director |
| Anil Dasu | Executive |
| Badri P Dasu | Executive |
| Mark Edwards | Director |
| Larry Hamel | Executive |
| Stephen J Hoffman | Director |
| Abhinav Jain | Director |
| Linda Judge | Executive |
| Richard King | Director, Executive |
| Carter King | Executive |
| Hamel G. Lawrence | Executive |
| Guy Nohra | Director |
| Pamela P Palmer | Director, Executive |
| Howard B Rosen | Director |
| Howie Rosen | Director |
| Thomas Schreck | Director |
| Steve Sullivan | Director |
| Mark Wan | Director |
| Mark B Weeks | Executive |
| James Welch | Executive |